Aims & Scope

Expert Review of Precision Medicine and Drug Development publishes primarily review articles covering the development and clinical application of medicine to be used in a personalized therapy setting; in addition, the journal also publishes original research and commentary-style articles.

In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, it has become necessary to identify patients responsive to treatments and treat patient populations using a tailored approach.

Areas covered include: Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this.

Clinical trials and case studies within personalized therapy and drug development.

Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment.

Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies.

Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 1.2

SJR (SCImago Journal Rank)

Year Value
2024 0.216

Quartile

Year Value
2024 Q4

h-index

Year Value
2024 17

Journal Rank

Year Value
2024 20298

Journal Citation Indicator

Year Value
2024 51

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.


Quick Facts

Current Factor
1.2
First Published: 2025

SJR (SCImago Journal Rank)

SJR
0.216
First Published: 2024

Quartile

Current Quartile
Q4
First Published: 2024

Similar Journals

Top Journals in Related Fields